Bumrungrad Hospital Valuation
Is BH-R undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of BH-R when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: BH-R (THB270) is trading above our estimate of fair value (THB248.38)
Significantly Below Fair Value: BH-R is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for BH-R?
Other financial metrics that can be useful for relative valuation.
What is BH-R's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | ฿214.63b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 7.8x |
Enterprise Value/EBITDA | 20.3x |
PEG Ratio | 5.5x |
Price to Earnings Ratio vs Peers
How does BH-R's PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 32.7x | ||
BDMS Bangkok Dusit Medical Services | 28.9x | 8.2% | ฿441.0b |
VIBHA Vibhavadi Medical Center | 41.5x | 35.6% | ฿25.8b |
BCH Bangkok Chain Hospital | 29.3x | 12.1% | ฿42.9b |
PR9 Praram 9 Hospital | 31x | 12.0% | ฿19.4b |
BH-R Bumrungrad Hospital | 28.3x | 5.1% | ฿214.6b |
Price-To-Earnings vs Peers: BH-R is good value based on its Price-To-Earnings Ratio (28.3x) compared to the peer average (32.7x).
Price to Earnings Ratio vs Industry
How does BH-R's PE Ratio compare vs other companies in the TH Healthcare Industry?
Price-To-Earnings vs Industry: BH-R is expensive based on its Price-To-Earnings Ratio (28.3x) compared to the TH Healthcare industry average (23x).
Price to Earnings Ratio vs Fair Ratio
What is BH-R's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 28.3x |
Fair PE Ratio | 28.5x |
Price-To-Earnings vs Fair Ratio: BH-R is good value based on its Price-To-Earnings Ratio (28.3x) compared to the estimated Fair Price-To-Earnings Ratio (28.5x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.